IQ DILI Consensus Opinion: Best Practices for Rechallenge Following Suspected Drug-Induced Liver Injury in Clinical Trials.
Saved in:
| Title: | IQ DILI Consensus Opinion: Best Practices for Rechallenge Following Suspected Drug-Induced Liver Injury in Clinical Trials. |
|---|---|
| Authors: | Steplewski K; GSK, Collegeville, PA, USA.; BridgeBio Inc., San Francisco, CA, USA., Walker L; GSK HQ, 79 New Oxford Street, London, UK., Coffee N; Sanofi, 450 Water Street, Cambridge, MA, 02141, USA. Nefeteria.Coffee@sanofi.com., Fallon M; Daiichi Sankyo UK Ltd., Uxbridge, UK., Yonemochi R; Daiichi Sankyo (China) Holdings Co., LTD, Shanghai, China., Alpers D; Washington University School of Medicine, St Louis, MO, USA., Rockey D; Digestive Disease Research Center, Charleston, SC, USA., Lewis J; Division of Gastroenterology, Georgetown University, Washington, DC, USA., Cohen E; Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA., Caminis J; Gilead Oncology, Patient Safety, US Parsippany, Parsippany, NJ, USA., Hey-Hadavi J; Pfizer, New York, NY, USA., Andrade RJ; Gastroenterology Service, University Hospital-IBIMA, CIBERehd, Málaga, Spain., Palmer M; Liver Consulting LLC New York, New York, NY, USA. |
| Source: | Drug safety [Drug Saf] 2025 Aug; Vol. 48 (8), pp. 855-874. Date of Electronic Publication: 2025 Apr 03. |
| Publication Type: | Consensus Statement; Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1942 |
|---|---|
| DOI: | 10.1007/s40264-025-01540-x |
